Advertisement
U.S. markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
77.57+0.17 (+0.22%)
At close: 04:00PM EDT
77.50 -0.07 (-0.09%)
After hours: 07:52PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
97.62B101.61B89.68B88.62B95.04B122.45B
Enterprise Value
165.55B165.52B154.93B143.63B150.05B173.53B
Trailing P/E
11.9912.0931.8822.9723.6739.32
Forward P/E
9.349.298.128.048.4310.54
PEG Ratio (5 yr expected)
1.120.360.311.361.261.26
Price/Sales (ttm)
0.280.290.270.270.300.39
Price/Book (mrq)
1.281.371.241.241.341.71
Enterprise Value/Revenue
0.461.761.731.621.762.07
Enterprise Value/EBITDA
9.1036.5532.0232.9433.5836.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.50
52-Week Change 32.66%
S&P500 52-Week Change 328.64%
52 Week High 383.25
52 Week Low 364.41
50-Day Moving Average 375.72
200-Day Moving Average 372.20

Share Statistics

Avg Vol (3 month) 311.04M
Avg Vol (10 day) 38.48M
Shares Outstanding 51.26B
Implied Shares Outstanding 61.26B
Float 81.25B
% Held by Insiders 10.15%
% Held by Institutions 183.10%
Shares Short (Feb 29, 2024) 424.17M
Short Ratio (Feb 29, 2024) 42.34
Short % of Float (Feb 29, 2024) 41.92%
Short % of Shares Outstanding (Feb 29, 2024) 41.92%
Shares Short (prior month Jan 31, 2024) 436.79M

Dividends & Splits

Forward Annual Dividend Rate 42.66
Forward Annual Dividend Yield 43.43%
Trailing Annual Dividend Rate 32.42
Trailing Annual Dividend Yield 33.13%
5 Year Average Dividend Yield 42.87
Payout Ratio 437.40%
Dividend Date 3Feb 01, 2024
Ex-Dividend Date 4Jan 19, 2024
Last Split Factor 22:1
Last Split Date 3Jun 07, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 2.34%
Operating Margin (ttm)3.67%

Management Effectiveness

Return on Assets (ttm)3.68%
Return on Equity (ttm)11.28%

Income Statement

Revenue (ttm)356.62B
Revenue Per Share (ttm)277.53
Quarterly Revenue Growth (yoy)12.00%
Gross Profit (ttm)N/A
EBITDA 18.44B
Net Income Avi to Common (ttm)8.34B
Diluted EPS (ttm)6.47
Quarterly Earnings Growth (yoy)-12.30%

Balance Sheet

Total Cash (mrq)11.45B
Total Cash Per Share (mrq)9.1
Total Debt (mrq)79.39B
Total Debt/Equity (mrq)103.59%
Current Ratio (mrq)0.86
Book Value Per Share (mrq)59.36

Cash Flow Statement

Operating Cash Flow (ttm)13.43B
Levered Free Cash Flow (ttm)11.08B